Topic starter
12/06/2026 10:04 pm
TL;DR: MedTech authorization is fragile when access logic lives inside application code, because ordinary updates can break role, context, audit, and break-glass rules at the point of care, according to Cerbos. Separating authorization into a managed policy layer turns update risk into governed change control rather than clinical disruption.
Editorial analysis by NHI Mgmt Group, based on content published by Cerbos: “Mapping business requirements to authorization policy for medtech”.
Key questions
Q: How should medtech teams prevent authorization policy drift during software updates?
A: They should externalize authorization into a managed policy layer so access rules can be reviewed and updated independently of application releases.
Q: Why does hard-coded authorization create risk in clinical applications?
A: Because clinical access is contextual and multi-actor, hard-coded rules are easy to disturb when code changes.
Q: What breaks when break-glass access is not tightly governed?
A: Break-glass access turns into permanent privileged backdoor risk when it is not tightly governed.
Practitioner guidance
- Externalize clinical authorization policy Move patient, delegate, physician, manufacturer, and emergency access rules into a dedicated policy layer so updates do not require application code changes.
- Model access by actor, resource, and context Define rules using patient relationship, hospital affiliation, device state, time, location, and consent instead of relying on coarse role checks alone.
- Separate break-glass from routine access Give emergency overrides distinct conditions, time limits, and audit events so clinicians can use them without weakening standard approval paths.
Bottom line: Embedded authorization in medtech increases the chance that ordinary code updates will alter access behaviour without a dedicated policy review.
Explore further
View Full Forum → | NHI Foundation Course → | Our Services → | Read the full analysis →
This topic was modified 7 days ago by NHI Mgmt Group
13/06/2026 12:35 am
Policy drift is the core medtech authorization failure, not just a coding inconvenience. When access rules are embedded in application code, routine releases can mutate clinical permissions without a distinct governance review. That creates a control problem across patient data, emergency access, and auditability because the organisation no longer knows whether the latest build still expresses the approved policy. The practitioner conclusion is simple: authorization needs its own lifecycle.
A question worth separating out:
Q: What is the difference between embedded and decoupled authorization in medtech?
A: Embedded authorization lives inside the application code, so policy changes travel with software releases. Decoupled authorization moves those decisions into a separate policy layer, making access rules easier to version, review, and audit without changing the clinical workflow itself.
👉 Read our full editorial: Decoupled authorization for medtech prevents policy drift
This post was modified 7 days ago by NHI Mgmt Group